Alerts will be sent to your verified email
Verify EmailKAMAHOLD
- Chemicals growth is the primary driver, contributing ~58% of incremental revenue; the investment case hinges on converting capital work-in-progress into productive capacity and sustaining recent chemical momentum.- Bull case requires concurrent chemical revenue strength and performance films recovery, while bear case materializes if both segments weaken simultaneously—the two segments account for 87% of the downside gap.
- The EBITDA margin pathway to 20.5% depends on mix shift to higher-margin chemicals and improved fixed-cost absorption, but model caps upside due to undisclosed pricing and input cost visibility.
Executive Snapshot:
Competitive Position: Wide Moat (Network Effects) — The platform holds a dominant liquidity advantage with 222K paying suppliers and 42M active buyers. However, the moat is Stable rather than widening. While network effects protect against new entrants, they are not currently driving new usage velocity at the bottom of the pyramid (Silver tier churn is high), indicating saturation or value-proposition mismatch for smaller SMEs.
| Scenario | Probability | Key Drivers |
|---|---|---|
| Base Case | 55-60% | Supplier base grows 3-4% CAGR; Revenue growth driven by 8-10% ARPU hikes; Margins stabilize ~35% due to reduced acquisition spend. |
| Bear Case | 25-30% | Elevated risk. Triggered if Standalone Collections growth stays <10% for 2 more quarters OR if entry-level churn forces price rollbacks. (See Section 5). |
| Bull Case | 15-20% | Requires specific breakout in 'Busy Infotech' scaling (>30% CAGR) AND successful stabilization of Silver bucket churn leading to >6K net adds/quarter. |
Base case probability is anchored by the persistent disconnect between management's aspiration (20%+ growth) and actual delivery (12% Consolidated Revenue growth in Q2 FY26). The Bear case is elevated above standard 20% because the core standalone engine shows signs of saturation (net additions were negative in Q3 FY25 and only modestly recovered to +2.8K in Q2 FY26).
Note: Base Year FY25 Actuals used. FY26 estimates annualized based on H1 FY26 actuals (Q1+Q2).
| Metric | FY25 (A) | FY26 (E) | FY27 (E) | FY28 (E) | FY29 (E) | FY30 (E) | CAGR |
|---|---|---|---|---|---|---|---|
| Revenue (Rs. Cr) | |||||||
| - Base Case (55-60%) | 1,388 | 1,585 | 1,805 | 2,055 | 2,340 | 2,665 | 13.7% |
| - Bear Case (25-30%) | – | 1,550 | 1,675 | 1,810 | 1,935 | 2,050 | 8.1% |
| - Bull Case (15-20%) | – | 1,620 | 1,945 | 2,330 | 2,800 | 3,360 | 19.3% |
| EBITDA (Rs. Cr) | |||||||
| - Base Case (55-60%) | 523 | 555 | 650 | 780 | 915 | 1,065 | 15.2% |
| - Bear Case (25-30%) | – | 535 | 550 | 580 | 600 | 615 | 3.8% |
| - Bull Case (15-20%) | – | 580 | 740 | 930 | 1,150 | 1,410 | 22.0% |
| EBITDA Margin | 37.7% | 35.0% | 36.0% | 38.0% | 39.1% | 40.0% | |
| PAT | 551 | 580 | 675 | 810 | 960 | 1,120 | 15.2% |
| PAT Margin | 39.7% | 36.6% | 37.4% | 39.4% | 41.0% | 42.0% | |
This section breaks down the total projected revenue increase (Base Case) into its component drivers.
ARPU Expansion & Tier Migration (~60% / Rs.648 Cr)
Net New Supplier Volume (~20% / Rs.216 Cr)
Accounting Software (Busy Infotech) (~15% / Rs.162 Cr)
Other Income/Adjacencies (~5% / Rs.54 Cr)
4.1 Revenue Growth Assumptions
4.2 Margin Trajectory Rationale
4.3 Key Risks to Estimates
4.4 Execution/Credibility Note
4.5 Data Limitations
Bear Case (FY30 Revenue Rs.2,050 Cr, 25-30% Prob):
Bull Case (FY30 Revenue Rs.3,360 Cr, 15-20% Prob):
Report is AI-generated and may contain inaccuracies. Analysis based on regulatory filings up to 2 hours prior to request.
| in % | Mar'24 | Jun'24 | Sep'24 | Dec'24 | Mar'25 | Jun'25 | Sep'25 | Dec'25 | Mar'26 | Jun'26 |
|---|---|---|---|---|---|---|---|---|---|---|
|
|
75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
|
|
75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
|
ABR Family Trust through its Trustees Ashish Bharat Ram and Kartik Bharat Ram
|
75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
|
KAI INDIA MENTAL HEALTH FORUM
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
SRF Holiday Home Limited
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
KARM FARMS LLP
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
SRISHTI WESTEND GREENS FARMS LLP
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
SRF Limited
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
SRF Middle East LLC
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
SRF Global BV
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
KAMA Realty (Delhi) Ltd
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
TYPSY BEAUTY PROCUREMENT SERVICES PRIVATE LIMITED
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Foreign Promoters
|
— | — | — | — | — | — | — | — | — | — |
|
|
25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
|
|
0.31 | 0.16 | 0.21 | 0.25 | 0.31 | 0.33 | 0.34 | 0.32 | 0.27 | 0.27 |
|
RICKY ISHWARDAS KIRPALANI
|
— | — | — | — | — | — | — | — | — | — |
|
KESWANI HARESH
|
— | — | — | — | — | — | — | — | — | — |
|
|
24.69 | 24.84 | 24.78 | 24.75 | 24.69 | 24.67 | 24.66 | 24.67 | 24.72 | 24.72 |
|
Individual < 2 lac
|
5.95 | 5.99 | 6.11 | 6.09 | 6.08 | 6.02 | 5.98 | 5.91 | 5.86 | 5.70 |
|
VISTRA ITCL (INDIA) LIMITED
|
5.97 | 5.98 | 5.95 | 5.95 | 5.95 | 5.95 | 5.95 | 5.95 | 5.95 | 5.95 |
|
RICKY ISHWARDAS KIRPALANI
|
4.70 | 4.70 | 4.70 | 4.70 | 4.70 | 4.70 | 4.71 | 4.71 | 4.71 | 4.71 |
|
Shares held by Custodians - DR
|
— | — | — | — | — | — | — | — | — | — |
|
No. of Shareholders
|
15,701 | 15,701 | 15,710 | 16,163 | 16,265 | 15,576 | 14,610 | 14,209 | 14,106 | 13,888 |